Enxiang Tao

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

State Key Laboratory of Natural Medicine(Current)

Enxiang Tao is an author at State Key Laboratory of Natural Medicine specializing in parkinson's disease pharmacotherapy, parkinson disease, and add-on therapy.

Publications per year

2022–2025

Publications

The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson’s Disease with Motor Fluctuations

Qianqian Wei, Yuyan Tan, Enxiang Tao et al. · CNS Drugs · 2022 · 27 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy

Mengying Zhang, Zhonghong Wei, Bin Wei et al. · Cell Host & Microbe · 2025 · 17 citations

Medicine, Cancer Biology, Oncology +15

1–2 of 2